These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31192282)

  • 41. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.
    Hamel-Desnos C; Desnos P; Wollmann JC; Ouvry P; Mako S; Allaert FA
    Dermatol Surg; 2003 Dec; 29(12):1170-5; discussion 1175. PubMed ID: 14725657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of sodium tetradecyl sulfate and polidocanol as sclerosants for leg telangiectasia based on histological evaluation with clinical correlation.
    Bush R; Bush P
    Phlebology; 2017 Aug; 32(7):496-500. PubMed ID: 27738241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of rubber band ligation with 3% polidocanol injection sclerotherapy for the treatment of internal haemorrhoids at a Nigerian tertiary hospital.
    Makanjuola A; Balogun OS; Osinowo AO; Adesanya AA; da Rocha JT
    Niger Postgrad Med J; 2020; 27(4):311-316. PubMed ID: 33154283
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bleomycin Polidocanol Foam (BPF) Stability - In Vitro Evidence for the Effectiveness of a Novel Sclerosant for Venous Malformations.
    Sun Y; Gu H; Yang X; Cai R; Shang Y; Hu L; Wang Y; Chen H; Lin X
    Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):1011-1018. PubMed ID: 32063463
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lingual Arteriovenous Malformation With Bleeding Treated With Polidocanol Foam Sclerotherapy Using Intestinal Forceps to Control Blood Flow.
    Sasaki Y; Sasaki S; Ishikawa K
    J Craniofac Surg; 2022 May; 33(3):e292-e293. PubMed ID: 34510063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.
    Carugo D; Ankrett DN; Zhao X; Zhang X; Hill M; O'Byrne V; Hoad J; Arif M; Wright DD; Lewis AL
    Phlebology; 2016 May; 31(4):283-95. PubMed ID: 26036246
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of glucose, glucose and polidocanol combination, liquid polidocanol and polidocanol foam in the treatment of reticular veins: A randomized study in rabbits.
    Lucio Filho CEP; Bertanha M; Prata MP; Carvalho LR; Jaldin RG; Sobreira ML; Janzen J; Yoshida WB
    Phlebology; 2021 May; 36(4):303-312. PubMed ID: 33030404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of polidocanol foam administration into rat peripheral veins on pulmonary parenchyma.
    de Moraes Silva MA; Ferreira RG; de Jesus-Silva SG; Cardoso RS; Miranda F
    Phlebology; 2018 Mar; 33(2):122-127. PubMed ID: 28092205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Foam sclerotherapy with Fibrovein (STD) for the treatment of hemorrhoids, using a flexible endoscope.
    Benin P; D'Amico C
    Minerva Chir; 2007 Aug; 62(4):235-40. PubMed ID: 17641583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Foam sclerotherapy: investigating the need for sterile air.
    de Roos KP; Groen L; Leenders AC
    Dermatol Surg; 2011 Aug; 37(8):1119-24. PubMed ID: 21615606
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 3% polidocanol foam sclerotherapy versus hemorrhoidal artery ligation with recto anal repair in hemorrhoidal disease grades II-III: a randomized, pilot trial.
    Neves S; Falcão D; Povo A; Castro-Poças F; Oliveira J; Salgueiro P
    Rev Esp Enferm Dig; 2023 Mar; 115(3):115-120. PubMed ID: 35638762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a 2-year follow-up.
    Ouvry P; Allaert FA; Desnos P; Hamel-Desnos C
    Eur J Vasc Endovasc Surg; 2008 Sep; 36(3):366-70. PubMed ID: 18524643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial.
    Ukritmanoroat T
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S35-40. PubMed ID: 21717876
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polidocanol foam sclerotherapy of persisting postoperative seromas after varicose vein surgery: a series of six cases.
    Moritz RK; Reich-Schupke S; Altmeyer P; Stücker M
    Phlebology; 2013 Oct; 28(7):341-6. PubMed ID: 22865419
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preliminary Experience With More Stable Polidocanol Foam in Sclerotherapy of Head and Neck Venous Malformations.
    Chen AW; Liu SH; Huang YY; Wang T
    Dermatol Surg; 2018 Nov; 44(11):1421-1426. PubMed ID: 29933299
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultrasound-guided sclerotherapy of the great saphenous vein with 1% vs. 3% polidocanol foam: a multicentre double-blind randomised trial with 3-year follow-up.
    Blaise S; Bosson JL; Diamand JM
    Eur J Vasc Endovasc Surg; 2010 Jun; 39(6):779-86. PubMed ID: 20206556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical results of polidocanol sclerotherapy in venous malformation treatment: Patient-perceived improvement and satisfaction.
    Çay F; Altunbulak AY; Özbay Y; Eldem G; Çil BE; Vargel İ; Kutluk MT; Yalçın B; Peynircioğlu B
    Phlebology; 2023 Feb; 38(1):36-43. PubMed ID: 36433742
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment for telangiectasias and reticular veins.
    Nakano LC; Cacione DG; Baptista-Silva JC; Flumignan RL
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD012723. PubMed ID: 34637138
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polidocanol for endovenous microfoam sclerosant therapy.
    Eckmann DM
    Expert Opin Investig Drugs; 2009 Dec; 18(12):1919-27. PubMed ID: 19912070
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An Investigation on the Influence of Hyaluronic Acid on Polidocanol Foam Stability.
    Chen AW; Liu YR; Li K; Liu SH
    Dermatol Surg; 2016 Jan; 42(1):56-8. PubMed ID: 26671207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.